Navigation Links
Kids' Obesity May Lead to Epidemic of Adult Diabetes
Date:7/8/2008

Impact has yet to be felt, since type 2 course may take 10 years to show, study says

TUESDAY, July 8 (HealthDay News) -- The current childhood obesity epidemic in the United States may lead to large numbers of young adults developing type 2 diabetes in the future, along with serious diabetes-related health complications, warns a University of Michigan researcher.

"The full impact of the childhood obesity epidemic has yet to be seen, because it can take up to 10 years or longer for obese individuals to develop type 2 diabetes. Children who are obese today are more likely to develop type 2 diabetes as young adults," Dr. Joyce Lee, a pediatric endocrinologist at the university's C.S. Mott Children's Hospital, said in a prepared statement.

The longer a person has diabetes, the more likely he or she is to develop serious complications such as kidney failure and blindness, Lee noted. That means that young adults with type 2 diabetes are much more likely to develop such complications during their lifetime than older people with the disease. She added that babies born to young women with type 2 diabetes are at greater risk for obesity and type 2 diabetes.

"Recent studies suggest that there have been dramatic increases in type 2 diabetes among individuals in their 20s and 30s, whereas it used to be that individuals developed type 2 diabetes in their late 50s or 60s. This may be the first indication of a type 2 diabetes epidemic among young adults who were obese during childhood," Lee said.

More needs to be done to fight childhood obesity, she urged in an article in the July issue of the journal Archives of Pediatric & Adolescent Medicine.

"Our society heavily invests in the treatment and management of chronic diseases like type 2 diabetes for adults. But it spends very little for the prevention and treatment of childhood obesity to stave off the onset of type 2 diabetes," Lee said.

"If there isn't a significant investment in obesity prevention and treatment during childhood within schools, communities, and the health care system, recent trends in childhood obesity will likely lead to increases in type 2 diabetes among young adults, resulting in even greater costs to society and the health care system."

Toward that end, the American Academy of Pediatrics (AAP) on Monday issued new cholesterol screening and treatment recommendations for children, including prescribing cholesterol-reducing drugs known as statins for some 8-year-olds.

The group also urged screening for young patients whose family history is unknown or those who have other heart disease risk factors including obesity, high blood pressure or diabetes. Screening, the AAP said, should take place after age 2, but no later than age 10.

More information

The Nemours Foundation has more about overweight and obese children.



-- Robert Preidt



SOURCE: University of Michigan Health System, news release, July 7, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Pediatricians Recommend Cholesterol Drugs for Some Kids
2. ADHD Might Raise Kids Obesity Risk
3. New Tests Assess Kids Sense of Smell, Taste
4. Spray Cuts Kids Pain When Getting IVs
5. UK and US guidelines on kids physical activity levels need rethinking
6. Kids connect alcohol odors with moms emotions
7. Traffic Pollution Puts Kids at Higher Allergy Risk
8. 2008 NAC Kids Olympics Celebrates the Achievements and Persevering Spirits of Hundreds of Children with Disabilities and Chronic Illnesses on Saturday, June 21, 2008 at Riverbank State Park
9. Vynamic Funds PAs First WARM2Kids Learning Center at Philadelphias R.W. Brown Community Center
10. High Blood Pressure in Kids Tracks Into Adulthood
11. Online Scheduler Helps Track Kids Shots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal ... to the end of November. , The Chicago, Illinois, based self-defense brand has been ... them about the ease of taking their personal safety into their own hands. , ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and continued ... have been awarded five-year accreditation status through the Public Health Accreditation Board ... by a PHAB-accredited health department now extend to more than 203 million ...
(Date:9/21/2017)... ... September 21, 2017 , ... In addition to sticking with ... more holistic approach and use natural alternatives for all house cleaning products, disinfectants, ... USDA guaranteeing that, the new line of essential oils, are all 100% organic ...
(Date:9/21/2017)... ... 2017 , ... The New England Center for Children® (NECC®), a global leader ... Hung to the Board of Directors. , “The New England Center for Children ... an invaluable addition to our team,” said Vincent Strully, Jr., President and CEO of ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: